# Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis

> **NCT06298019** · PHASE1 · RECRUITING · sponsor: **Stanford University** · enrollment: 21 (estimated)

## Conditions studied

- Dermatomyositis

## Interventions

- **BIOLOGICAL:** KYV-101

## Key facts

- **NCT ID:** NCT06298019
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-02
- **Primary completion:** 2027-04
- **Final completion:** 2039-04
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06298019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06298019, "Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06298019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*